NAPLEX Antifungal Practice Questions with Answers

Concept Explanation

NAPLEX antifungal therapy involves the clinical application of various drug classes, including azoles, echinocandins, and polyenes, to treat fungal infections while managing significant drug-drug interactions and organ toxicity. Pharmacists must understand the mechanism of action for each class: azoles inhibit the enzyme 14-alpha-demethylase to prevent ergosterol synthesis, echinocandins inhibit the synthesis of 1,3-beta-D-glucan in the cell wall, and polyenes like amphotericin B bind directly to ergosterol to create pores in the fungal membrane. Mastering this NAPLEX Prep resource requires balancing spectrum of activity—such as the unique coverage of Aspergillus and Candida species—with safety profiles, specifically monitoring for QTc prolongation with azoles and infusion-related reactions with amphotericin B. For those optimizing their study flow, using the AI MasterPlan can help structure your review of these complex pharmacologic agents.

Solved Examples

1. Question: A patient is prescribed fluconazole 400 mg IV daily. If the patient weighs 70 kg, what is the dose in mg/kg?
   Solution: Divide the total dose by the patient weight: $\frac{400 \text{ mg}}{70 \text{ kg}} = 5.71 \text{ mg/kg}$.
2. Question: An IV infusion of micafungin is prepared at a concentration of 0.5 mg/mL. The patient requires a 150 mg dose. What is the total volume to be administered?
   Solution: Use the formula $\text{Volume} = \frac{ \text{Dose}}{ \text{Concentration}}$. Therefore, $\frac{150 \text{ mg}}{0.5 \text{ mg/mL}} = 300 \text{ mL}$.
3. Question: Voriconazole 200 mg is ordered every 12 hours. How many total milligrams will the patient receive over a 48-hour period?
   Solution: The patient receives 2 doses per day (every 12 hours). Total doses in 48 hours = 4 doses. Total amount = $200 \text{ mg} \times 4 = 800 \text{ mg}$.

Practice Questions

1. Which antifungal agent is known to cause a dose-dependent decrease in the QTc interval rather than prolongation?
2. A patient receiving itraconazole capsules should be advised to take the medication with what type of beverage to ensure optimal absorption?
3. Which echinocandin requires no renal or hepatic dose adjustments in patients with mild to moderate impairment?

4. Amphotericin B deoxycholate is associated with significant infusion-related reactions. What premedication strategy is standard to prevent these?
5. Which azole antifungal has the most significant potential for hepatotoxicity and requires baseline and periodic monitoring of liver function tests?
6. Posaconazole oral suspension and tablets have different bioavailability profiles. Can they be interchanged dose-for-dose?
7. Which antifungal agent is the drug of choice for treating invasive aspergillosis?
8. A patient with severe renal impairment (CrCl < 30 mL/min) requires treatment for Candida albicans. Which formulation of voriconazole should be avoided due to the vehicle (SBECD)?
9. What is the primary mechanism of action of terbinafine in the treatment of onychomycosis?
10. Which antifungal agent is contraindicated in patients with heart failure due to a negative inotropic effect?

Answers & Explanations

1. Isavuconazonium sulfate. Unlike other azoles like fluconazole or voriconazole, isavuconazole is associated with QTc shortening.
2. An acidic beverage (e.g., cola). Itraconazole capsules require an acidic environment for dissolution and absorption; this should be avoided if the patient is on a PPI.
3. Anidulafungin. It undergoes chemical degradation in the blood rather than enzymatic metabolism, making it safe for patients with hepatic or renal issues.
4. Premedication with acetaminophen, diphenhydramine, and potentially corticosteroids or meperidine. These help manage rigors and fever associated with infusion.
5. Ketoconazole. While rarely used systemically now due to safety, it is the classic example of hepatotoxicity; among common agents, voriconazole also requires strict LFT monitoring.
6. No. The tablet has significantly higher bioavailability than the oral suspension.
7. Voriconazole. It is the gold standard for invasive aspergillosis as established by the Infectious Diseases Society of America (IDSA) guidelines.
8. The IV formulation. The cyclodextrin vehicle (SBECD) accumulates in renal failure.
9. Inhibition of squalene epoxidase. This leads to a deficiency of ergosterol and an accumulation of squalene, which is toxic to the fungal cell.
10. Itraconazole. It possesses a black box warning regarding the exacerbation of congestive heart failure.

Quick Quiz

Frequently Asked Questions

Why is voriconazole preferred for invasive aspergillosis?

Voriconazole has demonstrated superior efficacy in clinical trials compared to amphotericin B and has a more favorable side effect profile for long-term treatment of invasive pulmonary aspergillosis.

Are there drug interactions with azoles?

Yes, all azoles are potent inhibitors of the CYP450 enzyme system, particularly CYP3A4, which leads to significant interactions with medications like warfarin, statins, and benzodiazepines.

What is the role of the SBECD vehicle in antifungal therapy?

SBECD (sulfobutylether-beta-cyclodextrin) is a solubilizing agent used in IV voriconazole and posaconazole, which can accumulate in patients with significant renal impairment, potentially causing toxicity.

How do echinocandins differ from azoles in their spectrum?

Echinocandins are fungicidal against Candida species but are only fungistatic against Aspergillus, whereas azoles generally provide broader coverage including yeasts and molds.

Can you use fluconazole for Aspergillus infections?

No, fluconazole lacks activity against Aspergillus species and should not be used as monotherapy for these infections.

Tags

Enjoyed this article?

Share it with others who might find it helpful.

Share Article